Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 05/18: (ANN) (ASNA) (SGYP) Higher; (EBIO) (TSLA) (ENDP) Lower (more...)

May 18, 2015 9:31 AM
Eleven Biotherapeutics (NASDAQ: EBIO) 75.3% LOWER; announced top-line results from the OASIS study, the companys first pivotal Phase 3 study ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles